Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule

Shiho Suzuki, Koichi Hirata, Keisuke Suzuki et al.|Journal of the Neurological Sciences|2023

Cited by 2